TransMedics Group share price logo

TransMedics Group

NASDAQ: TMDX

Mid Cap

$93.97

+3.28

(+3.62%)

as on

TransMedics Group Stock Performance

as on August 20, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $90.21
    $94.99
    downward going graph

    4.00%

    Downside

    1.09%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $60.11
    $156.00
    downward going graph

    36.04%

    Downside

    66.01%

    Upside

    downward going graph

TransMedics Group share price movements today

Previous Close
$90.69
Open
$90.62
Volume
680.5K
Market Cap
$3.1B
Day's Low - High
$90.21 - $94.99
52 Week Low - High
$60.11 - $156.00

TransMedics Group Historical Returns

1 Month Return
+ 19.74 %
3 Month Return
+ 40.16 %
1 Year Return
-30.55 %
3 Year Return
+ 40.6 %
5 Year Return
+ 223.4 %

TransMedics Group Stock Fundamentals & Key Indicators

Check TransMedics Group market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1B

EPS (TTM)

1.559

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.56%

PE Ratio (TTM)

22.95

Industry PE ratio

23.86

PEG Ratio

1.2134

EBITDA

115.6M

Revenue (TTM)

668.5M

Profit Margin

22.69%

Return On Equity TTM

36.29%

TransMedics Group Stock Valuation

Track how TransMedics Group P/E has moved over time to understand its valuation trends.

TransMedics Group in the last 5 years

  • Overview

  • Trends

Lowest (-134.30x)

June 30, 2023

Today (22.95x)

August 17, 2026

Industry (23.86x)

August 17, 2026

Highest (163.92x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 22.95x

TransMedics Group vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TransMedics Group with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$3.1B223.4%22.9522.69%NA
BUY$130.1B26.77%35.2214.43%102.06%
BUY$52.8B-21.88%53.277.98%NA
BUY$116.1B-30.2%24.1565.02%3.15%
BUY$192.5B-11.49%3611.65%222.88000000000002%

Stock Returns calculator for TransMedics Group Stock including INR - Dollar returns

The TransMedics Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

TransMedics Group investment value today

Current value as on today

₹81,012

Returns

-₹18,988

(-18.99%)

Returns from TransMedics Group Stock

-₹26,327 (-26.33%)

Dollar Impact

₹7,339 (+7.34%)

Analyst Recommendation on TransMedics Group Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for TransMedics Group. Average target price of $97.3

TransMedics Group Share Price Target

Get share price movements and forecasts by analysts on TransMedics Group.

What analysts predicted

3.42%UPSIDE

Target Price

$97.3

Current Price

$93.97

Analyzed by

10 Analysts

Target

$97.30

TransMedics Group target price $97.3, a slight upside of 3.42% compared to current price of $93.97. According to 10 analysts rating.

Indian Investors' Interest in TransMedics Group Stock

Investment in TransMedics Group Shares on INDmoney has dropped by -26.95% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-26.95% versus previous 30 day period

Search interest for TransMedics Group Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

TransMedics Group Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
96
114
108
121
143
157
143
160
173
189
Gross Profit
59
69
60
72
88
96
84
93
101
113
Operating Income
12
12
3
8
27
36
23
21
13
23
EBITDA
20
20
13
16
36
46
33
32
27
26
Interest Expense
3
3
3
3
3
3
3
3
7
7
Depreciation
4
4
5
5
6
6
6
7
11
10
Income Before Tax
12
12
4
6
26
36
23
21
8
19
Income Tax Expense
0
0
0
0
0
1
-1
-83
1
4
Net Income
12
12
4
6
25
34
24
105
7
14
Net Profit Margin
12.59%
10.67%
3.88%
5.64%
17.89%
22.18%
16.91%
65.55%
4.21%
7.73%

TransMedics Group Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
7
13
23
25
30
93
241
441
605
Gross Profit
0
2
5
13
16
21
65
154
262
362
Operating Income
-22
-20
-20
-29
-26
-39
-31
-28
37
108
EBITDA
-22
-19
-20
-27
-23
-38
-28
-7
69
148
Interest Expense
0
1
2
4
3
3
3
10
14
13
Depreciation
-
0
0
1
1
1
3
5
19
27
Income Before Tax
-24
-20
-23
-33
-28
-44
-36
-26
35
107
Income Tax Expense
0
0
0
0
0
0
0
-1
0
-82
Net Income
-24
-20
-23
-33
-28
-44
-36
-25
35
190
Net Profit Margin
-387.58%
-270.96%
-182.50%
-142.12%
-112.13%
-146.11%
-38.77%
-10.36%
8.03%
31.43%

TransMedics Group Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
12
4
6
25
34
24
105
7
14
Operating Cash Flow
25
6
19
-2
91
69
34
24
17
Investing Cash Flow
-23
-47
-13
-27
-9
-7
-15
-36
-7
Financing Cash Flow
10
7
1
3
7
3
3
3
0
Change in Cash
12
-32
6
-26
90
65
22
-8
10

TransMedics Group Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-23
-33
-28
-44
-36
-25
35
190
Operating Cash Flow
-23
-25
-32
-30
-28
-45
-13
48
192
Investing Cash Flow
24
12
-60
-41
29
54
-193
-129
-59
Financing Cash Flow
0
22
92
75
1
167
400
22
16
Change in Cash
2
8
0
4
0
175
193
-58
151

Mutual Funds that own TransMedics Group Stock

Check out the Mutual Funds with significant holdings in TransMedics Group.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
7.466858%
2589144
Delaware Group Equity Funds V
4.781782%
1658090
Fidelity Securities Fund
4.045702%
1402853
Fidelity Contrafund
2.763651%
958300
LAZARD FUNDS INC
2.238657%
776257

Global Institutional Holdings in TransMedics Group

Funds
Holdings
iShares
11.48%
Vanguard
9.11%
SPDR
2.03%
Invesco
1.2%
YieldMax
0.83%

TransMedics Group News & Key Events

  • img

    Today's Timeline - 08 March

    Sun, 01:45 PM

    -

    TransMedics reports 2025 revenue of $605.5 million, a 37% increase, with OCS Liver accounting for 36% of U.S. transplants.

    Mon, 03:40 AM

    -

    TransMedics Group faces short-term share price decline despite strong long-term performance and fundamentals.

Insights on TransMedics Group

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TMDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 143.82M → 189.94M (in $), with an average increase of 8.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 7.31M → 14.68M (in $), with an average increase of 50.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, TMDX stock has moved up by 27.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 13.4% return, outperforming this stock by 36.3%

About TransMedics Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
OrganisationTransMedics Group
Headquarters200 Minuteman Road, Andover, MA, United States, 01810
IndustryMedical Devices
CEODr. Waleed H. Hassanein M.D.
E-voting on sharesClick here to vote

Key Management of TransMedics Group

Name

Title

Mr. Matthew Forsyth

Senior VP, General Counsel & Corporate Secretary

Ms. Miriam C. Provost Ph.D.

Vice President of Global Regulatory Affairs

Dr. Waleed H. Hassanein M.D.

Founder, President, CEO & Director

Mr. Gerardo Hernandez

CFO & Treasurer

Mr. Nicholas Corcoran

Senior Vice President of Supply Chain & Operations

Dr. Tamer I. Khayal M.D.

Senior Vice President of International

Mr. Anil Ranganath

Advisor

FAQs

What is TransMedics Group share price today?

TransMedics Group share price today is $93.97 as on at the close of the market. TransMedics Group share today touched a day high of $94.99 and a low of $90.21.

What is the 52 week high and 52 week low for TransMedics Group share?

TransMedics Group share touched a 52 week high of $156.00 on and a 52 week low of $60.11 on . TransMedics Group stock price today i.e. is closed at $93.97,which is 39.76% down from its 52 week high and 56.34% up from its 52 week low.

What is TransMedics Group's market capitalisation today?

TransMedics Group market capitalisation is $0.00T as on .

How to invest in TransMedics Group Stock (TMDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for TransMedics Group on INDmoney app. Click on Buy button. You can invest as low as $1.5 in TransMedics Group Shares that will get you 0.0160 shares as per TransMedics Group share price of $93.97 per share as on August 20, 2026 at 8:45 am IST.

What is the minimum amount required to buy TransMedics Group Stock (TMDX) from India?

Indian investors can start investing in TransMedics Group (TMDX) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in TransMedics Group stock (as per the Rupee-Dollar exchange rate as on ). Based on TransMedics Group share’s latest price of $93.97 as on August 20, 2026 at 8:45 am IST, you will get 0.1064 shares of TransMedics Group. Learn more about fractional shares .

What are the returns that TransMedics Group has given to Indian investors in the last 5 years?

TransMedics Group stock has given 223.4% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?